Bitcoin and Ethereum spot ETFs record $385 million and $38 million, respectively, as institutions extend the accumulation ...

The market is expected to consolidate after the two-day rally and may attempt another session of upward movement. Below are ...

Novavax's full FDA approval for NUVAXOVID is a transformative milestone, unlocking a $175M Sanofi payment and validating ...

Discover the top stock picks by market experts Raja Venkatraman, MarketSmith India, Ankush Bajaj, and Trade Brains for Friday ...

Mutuum Finance (MUTM) is in its fourth presale phase after raising $7,900,000 from ... returns than Solana and can generate potential portfolio growth ten times larger than SOL’s current $ ...

Market uncertainty and muted returns in 2025 make portfolio stability and income reliability crucial. Check out two stocks to ...

Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Umecrine Cognition has resumed the inclusion of patients to the clinical phase 1b/2a trial evaluating ...

From Phase 1 to Phase 14 ... However, no long-term portfolio restructuring is planned, as we are all geared up to witness the final Nirvana move in Berkshire's cycle. Disclaimer: This analysis ...

Lennar transferring its land banking assets into Millrose. Millrose will now be responsible for acquiring, developing, and ...

The US Department of the Treasury will officially be phasing out the penny from circulation once the current stock of blanks for minting is used up. Brad Smith reports more on this news.

Merus shares surged over 35% after reporting a 63% response rate and 79% 12-month survival in a phase 2 trial. Analysts raised price targets on optimism the data could support accelerated approval ...

STOCKHOLM, SWEDEN – May 26, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Umecrine Cognition has resumed the inclusion of patients to the clinical ...